Q4 2020 Holdings
Filed 2021-02-16 | 12 holdings | $58.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $47.1M | 662,958 | 81.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $7.6M | 228,595 | 13.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $3.0M | 35,200 | 5.2% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $120.1K | 938,490 | 0.2% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $86.6K | 952,847 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $57.3K | 260,876 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $19.6K | 114,900 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $9.2K | 199,269 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $5.6K | 197,191 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $1.2K | 36,534 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $718 | 61,313 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $372 | 6,000 | 0.0% |